APSR2026-804

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP08-012
P67
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1210886-46904-APSR Pleural ADA_440318.pdf
Format: PDF Only
06. Tuberculosis
12

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Ying Hoey Lim * Ampang Hospital  Respiratory Unit, Department of Internal Medicine Selangor Malaysia
Sze Kye Teoh - Ampang Hospital  Respiratory Unit, Department of Internal Medicine Selangor Malaysia
Yu Wei Cheah - Ampang Hospital  Respiratory Unit, Department of Internal Medicine Selangor Malaysia
Wen Yi Lee - Ampang Hospital  Respiratory Unit, Department of Internal Medicine Selangor Malaysia
Thian Hao Ho - Ampang Hospital  Respiratory Unit, Department of Internal Medicine Selangor Malaysia
Puteri Nur Athirah Megat Mohamad Aminuddin - Ampang Hospital  Respiratory Unit, Department of Internal Medicine Selangor Malaysia
Siti Nabilah Afni Pakururazi - Ampang Hospital  Respiratory Unit, Department of Internal Medicine Selangor Malaysia
Fatin Farhana Suhni - Ampang Hospital  Respiratory Unit, Department of Internal Medicine Selangor Malaysia
Muhammad Zuhri Zainudin - Ampang Hospital  Respiratory Unit, Department of Internal Medicine Selangor Malaysia
Kar Seng Tan - Ampang Hospital  Respiratory Unit, Department of Internal Medicine Selangor Malaysia
Muhammad Shahir Abdul Razak - Ampang Hospital  Respiratory Unit, Department of Internal Medicine Selangor Malaysia
Ruzana Dayanna Zawawi - Ampang Hospital  Microbiology Unit, Department of Pathology Selangor Malaysia
 
 
 
Presenting Author Details
Ying Hoey
Lim
yinghoey@gmail.com
+60124056030
31-40
Malaysia
Original Research
Pleural Fluid ADA in a Real-World Cohort: Diagnostic Accuracy, Determinants and Clinical Pitfalls
Maximum 25 words
Abstract Content
Pleural fluid adenosine deaminase (ADA) is widely used as a rule-in test for tuberculous pleural effusion (TBE), particularly in high-burden settings. However, its specificity in heterogeneous real-world populations and its interaction with pleural biochemical characteristics remain incompletely defined. We aimed to evaluate the diagnostic performance of ADA and identify clinically relevant, context-dependent misclassification patterns.
We conducted a retrospective observational study of 520 patients undergoing pleural fluid ADA testing in a tertiary centre. Final diagnoses were established using integrated clinical, microbiological and radiological data, with TBE defined by confirmed cases. Diagnostic performance was assessed using ROC analysis with the optimal cut-off determined by the Youden index. Subgroup analyses were performed according to pleural fluid classification (transudate vs exudate) and biochemical parameters, including protein and lactate dehydrogenase (LDH).
Of 520 patients, 21.7% had TBE. ADA demonstrated good overall diagnostic performance (AUC 0.891, 95% CI 0.849–0.929). The optimal cut-off of 29.9 U/L showed strong discriminative ability (sensitivity of 90.9%, specificity of 87.7%) and a Youden index of 0.786. Elevated ADA was almost exclusively confined to exudative effusions, with only 1.1% of transudates demonstrating ADA ≥30 U/L. Among patients with elevated ADA, approximately 21% did not have TBE. These false-positive results were not randomly distributed but occurred predominantly in inflammatory effusions, particularly empyema, parapneumonic effusions and lymphoma. Biochemical patterns further distinguished these groups: high ADA in conjunction with markedly elevated LDH was strongly associated with inflammatory effusions, whereas TBE cases demonstrated comparatively lower LDH levels. In addition, patients with false-positive ADA were older than those with TBE, indicating reduced specificity with increasing age.
Pleural fluid ADA is a highly sensitive biomarker for diagnosing tuberculous pleural effusion (TBE), particularly at a threshold of 29.9 U/L. However,clinicians must remain alert to diagnostic pitfalls. False positives are especially common in older demographics and in patients with severe inflammatory exudates. Ultimately, ADA should not be evaluated in isolation. By factoring in the patient's age and checking for notably high LDH levels, clinicians can successfully separate true TBE from other inflammatory conditions in real-world settings.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Adenosine deaminase; tuberculosis; pleural effusion
maximum 3 keywords and no abbreviations, separated by commas
 
351